Stockscreener 앱 받기
17.41
0.81%
0.114
Baxter International Inc 주식(BAX)의 최신 뉴스
Baxter Launches Pilot Program for Therapy Animals in Healthcare Settings - respiratory-therapy.com
Baxter International Provides FY 2026 Earnings Guidance - National Today
Baxter (NYSE: BAX) exec holds 31K shares plus 25.9K options - Stock Titan
Baxter (NYSE: BAX) surgery chief lists common shares and option grants - Stock Titan
[Form 3] BAXTER INTERNATIONAL INC Initial Statement of Beneficial Ownership - Stock Titan
J&J Defends Blood-Clotting Powder IP From Baxter Attack - Law360
Robotic Pharmacy Prescription Market Research and Global Forecast Report 2025-2032 - GlobeNewswire Inc.
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Baxter to Host First-Quarter 2026 Financial Results Conference Call for Investors - marketscreener.com
Medical Syringe Market Is Booming So Rapidly Growth by 2033| - openPR.com
Hologic hires former Baxter International chief as next CEO - Radiology Business
Baxter International Inc. (BAX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Fund Update: 3,614,465 BAXTER INTERNATIONAL (BAX) shares added to GREENHAVEN ASSOCIATES INC portfolio - Quiver Quantitative
Evercore ISI Group Lowers Price Target for Baxter International (BAX) to $22 | BAX Stock News - GuruFocus
Baxter Introduces the IV Verify Line Labeling System, an Automated Solution to Improve IV Labeling in Healthcare Settings - Bioscience Association Manitoba
Evercore ISI Adjusts Baxter International Price Target to $22 From $23, Maintains Outperform Rating - marketscreener.com
Evercore Maintains Baxter International Inc(BAX.US) With Buy Rating, Cuts Target Price to $22 - 富途牛牛
Assessing Baxter (BAX) Valuation After Launch Of IV Verify Line Labeling System - simplywall.st
Aug PreEarnings: Can Baxter International Inc deliver alphaEarnings Miss & Reliable Price Breakout Signals - baoquankhu1.vn
Does Baxter’s New IV Verify Labeling System Redefine Its Automation Edge In Healthcare Workflow Efficiency (BAX)? - Sahm
How Investors May Respond To Baxter International (BAX) Expanding Into Automated IV Line Labeling Systems - Yahoo Finance
BAXTER INTERNATIONAL INC. R (BTL.HM) Q2 FY2025 earnings call transcript - Yahoo Finance
Baxter International unveils IV Verify to enhance IV labeling accuracy - msn.com
List of 21 Acquisitions by Baxter (Apr 2026) - Tracxn
Columbia Intrinsic Value Fund's Baxter International Inc(BAX) Holding History - GuruFocus
Baxter’s IV Verify Launch Tests Medication Safety Strategy And Hospital Traction - simplywall.st
Baxter International Introduces IV Verify to Improve the Precision of IV Labeling - Bitget
Baxter International Unveils IV Verify to Enhance IV Labeling Accuracy - Yahoo Finance
Pet Partners, Baxter Foundation Expand Therapy Animal Programs for Patients, Healthcare Workers - Pet Age
Baxter (BAX) Unveils New IV Verify Line Labeling System for Nurs - GuruFocus
Baxter International Inc. stock outperforms competitors despite losses on the day - MarketWatch
Baxter International Hits New 52-Week Low at $15.87 - Markets Mojo
Baxter International Inc (BAX) Stock Price Down 4.2% on Mar 30 - GuruFocus
Baxter launches IV labeling system aimed at improving safety, efficiency - Medical Economics
Pet Partners and the Baxter Foundation Expand Therapy Animal Programs to Support 100,000 Patients and Healthcare Workers in Two-Year Pilot - Bioscience Association Manitoba
Baxter debuts automated IV line labeling system By Investing.com - in.investing.com
Baxter debuts automated IV line labeling system - Investing.com
Baxter Foundation Therapy Animal Push And What It Means For Investors - Sahm
Baxter stock price forecast: bearish trend persists as BAX trades near 52-week lows - Traders Union
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
Baxter International (NYSE:BAX) Hits New 1-Year LowTime to Sell? - MarketBeat
Baxter International stock hits 52-week low at 16.07 USD By Investing.com - Investing.com Australia
Baxter International stock hits 52-week low at 16.07 USD - Investing.com
BAX SEC FilingsBaxter Intl Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Clinical Nutrition for Cancer Care: 2026-2030 Market - GlobeNewswire
Clinical Nutrition for Cancer Care: 2026-2030 Market Analysis Featuring Profiles of Leading PlayersAbbott Nutrition, Baxter International, B Braun Melsungen, Nestle Health Science, Danone Nutricia and More - Yahoo Finance
Bank of America maintains a hold rating on Baxter International (BAX) - MSN
Baxter International Stock: Navigating Leadership Changes and Portfolio Optimization Amid Market Pre - AD HOC NEWS
Bank of America Maintains a Hold Rating on Baxter International (BAX) - Insider Monkey
A Look At Baxter International (BAX) Valuation As CFO Transition Draws Investor Attention - simplywall.st
Baxter International Inc. stock underperforms Thursday when compared to competitors - MarketWatch
[SCHEDULE 13G/A] BAXTER INTERNATIONAL INC Amended Passive Investment Disclosure - Stock Titan
SG Americas Securities LLC Has $32.97 Million Stock Position in Baxter International Inc. $BAX - MarketBeat
Baxter to Host Annual Meeting of Stockholders in Virtual Format - marketscreener.com
Baxter investors get online-only annual meeting, with voting on May 5 - Stock Titan
Baxter International stock faces pressure from ifosfamide shortage and reduced production capacity a - AD HOC NEWS
0.32%
0.26%
자본화:
|
볼륨(24시간):